PHI with Hazelnut pollen allergy
How does this condition affect your private health insurance?
Haselnusspollenallergie, or hazelnut pollen allergy, is a common seasonal allergic reaction triggered by airborne hazelnut pollen, typically occurring in late winter and early spring. It manifests as allergic rhinitis (sneezing, runny nose, nasal congestion), conjunctivitis (itchy, watery eyes), and sometimes allergic asthma (wheezing, shortness of breath). Many individuals also experience oral allergy syndrome when consuming certain fruits, vegetables, or nuts due to cross-reactivity with hazelnut pollen proteins. Diagnosis involves skin prick tests or specific IgE blood tests. Management includes antihistamines, nasal corticosteroids, and in severe cases, allergen-specific immunotherapy. While not life-threatening itself, severe reactions can impair quality of life.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to a few weeks, depending on pollen exposure.
Duration of Illness (Lifetime)
Chronic, recurring seasonally for many years or a lifetime.
Cost of Treatment (Initial)
Approximately 50-300 USD (doctor visit, allergy testing, initial medication).
Cost of Treatment (Lifetime)
Approximately 1,000-10,000+ USD (annual medication, potential long-term immunotherapy).
Mortality Rate
Extremely low, nearly zero. (Severe asthmatic reactions are rare but possible.)
Risk of Secondary Damages
Moderate (e.g., chronic sinusitis, sleep disturbances, impaired quality of life, development of asthma).
Probability of Full Recovery
Low spontaneously; moderate to high with successful allergen-specific immunotherapy.
Underlying Disease Risk
Increased probability of developing other allergic conditions such as asthma, atopic dermatitis, or other pollen/food allergies (allergic march).